Endocrine Pharmacology Practice Questions

Q: Which of the following are major complications of oral pills? 1. Cholestasis jaundice 2. Chloasma and acne 3. Venous thromboembolism 4. Breast cancer Select the correct answer using the code given below.

1, 2 and 3. ***1, 2 and 3*** - **Cholestasis jaundice** is a rare but serious hepatic complication of oral contraceptive pills (OCPs), caused by the estrogen component leading to impaired bile flow. - **Venous thromboembolism (VTE)** is one of the most serious and well-documented major complications of OCPs, with increased risk particularly in the first year of use and with higher estrogen doses. - **Chloasma and acne** are common dermatological side effects of OCPs. While technically not "life-threatening major complications," they are clinically significant adverse effects that affect quality of life and compliance. Some classifications include these as "major" due to their frequency and impact on continuation. - Note: The distinction between "major complications" and "common side effects" can vary by source. This answer reflects the inclusive interpretation. *1, 3 and 4* - This option includes **breast cancer** as a major complication. Current evidence shows a small increased risk during active use that diminishes after discontinuation. However, the relationship is complex and not consistently classified as a "major complication" in standard teaching. - It excludes **chloasma and acne**, which are very common adverse effects frequently listed among OCP-related problems. *1, 2 and 4* - This option includes **breast cancer**, which has nuanced and often conflicting evidence regarding its association with OCPs. - It excludes **venous thromboembolism**, which is indisputably the most serious life-threatening complication of oral contraceptive use and must be included in any list of major complications. *2, 3 and 4* - This option excludes **cholestasis jaundice**, which is a recognized serious hepatic complication of OCPs. - It incorrectly includes **breast cancer** as a major complication while omitting cholestatic jaundice, which is more consistently classified as a complication in pharmacology texts.

Q: Ulipristal acetate (progesterone receptor modulator) should not be prescribed as emergency contraceptive in women with

liver dysfunction. ***Correct: liver dysfunction*** - **Ulipristal acetate** is extensively metabolized in the **liver** by the CYP450 enzyme system, predominantly CYP3A4. - In individuals with **severe hepatic impairment**, the metabolism of ulipristal acetate can be impaired, leading to increased plasma concentrations and potential adverse effects. - **Severe liver dysfunction** is a documented contraindication in product labeling. *Incorrect: glaucoma* - There is **no known contraindication** for ulipristal acetate use in individuals with **glaucoma**. - Its mechanism of action primarily involves progesterone receptors and does not directly impact intraocular pressure. *Incorrect: coagulopathy* - Ulipristal acetate does **not significantly affect blood coagulation** parameters or platelet function. - It is not contraindicated in individuals with **coagulopathy**, unlike some estrogen-containing contraceptives. *Incorrect: kidney failure* - While urinary excretion of ulipristal acetate metabolites occurs, the **primary elimination pathway is fecal** (approximately 90%). - **Kidney failure** is not considered a contraindication, and dose adjustments are generally not required.

Q: All of the following are correct regarding drospirenone EXCEPT:

It is safe in renal failure patients.. ***4. It is safe in renal failure patients*** - **Drospirenone** has **antimineralocorticoid activity**, which can lead to **hyperkalemia**, especially in patients with **renal impairment**. - Therefore, it is **contraindicated** and not safe in patients with **renal failure** due to the increased risk of potentially life-threatening **hyperkalemia**. *3. It has antimineralocorticoid action* - Drospirenone is a unique progestin derived from **spironolactone**, giving it a distinct **antimineralocorticoid effect**. - This effect helps to reduce symptoms like **bloating** and **fluid retention**, which are often associated with other hormonal contraceptives. *2. It has antiandrogenic property* - Drospirenone possesses significant **antiandrogenic properties**, which are beneficial in treating conditions like **acne** and **hirsutism**. - This action helps to counteract the androgenic side effects some other progestins might exhibit, making it a favorable choice for women who experience these issues. *1. It is a fourth generation progestin* - Drospirenone is classified as a **fourth-generation progestin**, developed to offer an improved side effect profile compared to older progestins. - These newer progestins often have more selective receptor binding and distinct pharmacological properties like **antiandrogenic** and **antimineralocorticoid** effects.

Q: Which of the following drugs should be avoided in labouring women with bronchial asthma?

Prostaglandin F2α. ***Prostaglandin F2α*** - **Prostaglandin F2α** (e.g., **carboprost**) is a potent **bronchoconstrictor** and can exacerbate asthma, leading to severe respiratory distress in susceptible individuals. - Its use for **uterine atony** in labouring women with a history of asthma is generally contraindicated due to the risk of inducing an **asthma attack**. *Ergometrine* - **Ergometrine** is an **ergot alkaloid** used to prevent or treat **postpartum hemorrhage** by causing sustained uterine contractions. - While it can cause some adverse effects like nausea or hypertension, it is **not generally contraindicated** in asthma and does not directly cause bronchoconstriction. *Prostaglandin E1* - **Prostaglandin E1** (e.g., **misoprostol**) is used for cervical ripening and induction of labour, or for preventing postpartum hemorrhage. - It generally has **bronchodilating** properties and is therefore considered safe for use in patients with asthma. *Opioid analgesics* - **Opioid analgesics** (e.g., **pethidine**, **morphine**) are commonly used for pain relief during labour. - While they can cause respiratory depression at high doses, they do **not directly induce bronchoconstriction** and are generally safe for use in asthmatic patients when carefully monitored.

Q: What is the content of ethinyl estradiol in very low dose oral contraceptives ?

20 µg. ***20 µg*** - Very low-dose oral contraceptives typically contain **20 µg of ethinyl estradiol**. This dosage is chosen to minimize estrogen-related side effects while maintaining contraceptive efficacy. - While it offers fewer side effects, its **contraceptive reliability** might be slightly lower than standard doses, and it could lead to more **breakthrough bleeding**. *15 µg* - Oral contraceptives with **15 µg of ethinyl estradiol** are considered ultra-low dose and are less common. - This dosage carries a higher risk of **breakthrough bleeding** and potentially reduced efficacy compared to 20 µg. *25 µg* - An oral contraceptive containing **25 µg of ethinyl estradiol** falls within the low-dose range, but it is not classified as "very low dose" given that 20 µg is the typical threshold for that designation. - While still generally well-tolerated, it contains slightly more estrogen than the very low-dose options. *30 µg* - This concentration of ethinyl estradiol is characteristic of **low-dose oral contraceptives**, but not "very low dose." - It offers good contraceptive efficacy with a relatively low incidence of estrogen-related side effects.

Q: Consider the following list of cancers: 1. Ovarian cancer 2. Colon cancer 3. Endometrial cancer 4. Breast cancer What is the effect of combined oral contraceptive pills on the above?

Protection against 1, 2 and 3. **Protection against 1, 2, and 3** - Combined oral contraceptive (COC) pills are known to **reduce the risk of ovarian and endometrial cancer**, effects that can persist for decades after discontinuation. This is primarily due to the suppression of ovulation and the direct effect of progestin on the endometrium. - COC use also offers some **protection against colorectal cancer**, with studies showing a modest reduction in risk, potentially related to changes in bile acid metabolism or other hormonal effects. *Increased risk of 3 and 4 only* - While COCs **decrease the risk of endometrial cancer (3)**, they are associated with a **modest, temporary increase in the risk of breast cancer (4)**, which typically returns to baseline 10 years after cessation. - This option incorrectly states an increased risk for endometrial cancer and doesn't account for the protective effects on ovarian and colon cancer. *Decreased risk of 1 and 2 only* - COCs do **decrease the risk of ovarian cancer (1) and colon cancer (2)**. - However, this option is incomplete as it overlooks the significant protective effect on **endometrial cancer (3)**. *Increased risk of 2 and 3 only* - COCs actually **decrease the risk of both colon cancer (2) and endometrial cancer (3)**. - This statement directly contradicts the established protective effects of COCs on these cancer types.

Q: Which one of the following is not a third generation progestogen used in combined oral contraceptive pills ?

Levonorgestrel. ***Levonorgestrel*** - **Levonorgestrel** is a **second-generation progestogen** commonly used in combined oral contraceptive pills and emergency contraception. - While effective, it tends to have higher androgenic activity compared to third-generation progestogens. *Norgestimate* - **Norgestimate** is a **third-generation progestogen** known for its lower androgenic activity. - It is often favored in combined oral contraceptives to minimize androgenic side effects like acne and hirsutism. *Gestodene* - **Gestodene** is a **third-generation progestogen** that has minimal androgenic activity and high progestational potency. - It is frequently included in modern combined oral contraceptives to improve cycle control and reduce side effects. *Desogestrel* - **Desogestrel** is also a **third-generation progestogen** and is an active metabolite of etonogestrel. - It is characterized by its low androgenic effects and is used in various combined oral contraceptive formulations.

Q: Post coital contraception is achieved by all except

High degree of progesterone. ***High degree of progesterone*** - A *high degree of progesterone* is associated with **maintaining pregnancy**, not preventing it. - Progesterone supports the endometrium and maintains the corpus luteum, which are essential for pregnancy continuation. - While synthetic progestins (like levonorgestrel) are used in emergency contraception, they work through different mechanisms (ovulation inhibition, altered cervical mucus) at specific low doses, not as "high degree of progesterone" [2]. - High progesterone levels are NOT used for post-coital contraception. *By administration of RU 486* - **RU 486 (mifepristone)** is a progesterone receptor antagonist effective for post-coital contraception and medical abortion [1]. - It blocks progesterone action, causing decidual necrosis and preventing implantation or terminating early pregnancy [1]. - Commonly used as emergency contraception and for early medical abortion [1]. *Administration of prostaglandins* - **Prostaglandins** (like misoprostol) cause uterine contractions and cervical ripening [1]. - Used in combination with mifepristone for medical abortion [1]. - Can prevent implantation or induce abortion when administered post-coitally [1]. *High dose estrogens* - **High-dose estrogens** were historically used for post-coital contraception (Yuzpe regimen combined estrogen-progestin). - Work by inhibiting or delaying ovulation, interfering with corpus luteum function, and altering the endometrium to prevent implantation. - Effective when administered within 72 hours of unprotected intercourse.

Q: Mifepristone used for inducing abortion acts on :

Progesterone receptors. ***Progesterone receptors*** - **Mifepristone** is a **progesterone receptor antagonist**, meaning it blocks the action of progesterone [1]. - In pregnancy, **progesterone** is crucial for maintaining the uterine lining and preventing contractions, so blocking its action leads to **endometrial shedding** and uterine contractions [1].*Uterine contractility* - While mifepristone ultimately affects **uterine contractility**, this is an **indirect effect** of blocking progesterone [1]. - The direct action is on the **receptors themselves**, not the contractility mechanism.*Hypothalamopituitary ovarian axis* - Mifepristone does **not primarily act** on the **hypothalamic-pituitary-ovarian axis**. - Its main effect is directly on the **uterine tissue** by blocking progesterone's local action.*All of the options* - As mifepristone's primary and direct mechanism is through **progesterone receptor antagonism**, this option is incorrect [1]. - The effects on uterine contractility are secondary to its receptor blockade.

Question 1

Under which one of the following conditions, the HPA axis suppression is likely to result in crisis due to adrenal insufficiency following withdrawal of glucocorticoids?

Accepted Answer

If glucocorticoids have been prescribed repeatedly within the previous year

Answer

If the dose is less than equivalent of 5 mg prednisolone per day

Answer

If glucocorticoids have been given by intravenous route for five days

Answer

If glucocorticoids have been administered orally for one week

Question 2

Which of the following are major complications of oral pills?

1. Cholestasis jaundice
2. Chloasma and acne
3. Venous thromboembolism
4. Breast cancer

Select the correct answer using the code given below.

Accepted Answer

1, 2 and 3

Answer

1, 3 and 4

Answer

1, 2 and 4

Answer

2, 3 and 4

Question 3

Ulipristal acetate (progesterone receptor modulator) should not be prescribed as emergency contraceptive in women with

Accepted Answer

liver dysfunction

Answer

glaucoma

Answer

coagulopathy

Answer

kidney failure

Question 4

All of the following are correct regarding drospirenone EXCEPT:

Accepted Answer

It is safe in renal failure patients.

Answer

It has antimineralocorticoid action.

Answer

It is a fourth generation progestin.

Answer

It has antiandrogenic property.

Question 5

Which of the following drugs should be avoided in labouring women with bronchial asthma?

Accepted Answer

Prostaglandin F2α

Answer

Ergometrine

Answer

Prostaglandin E1

Answer

Opioid analgesics

Question 6

What is the content of ethinyl estradiol in very low dose oral contraceptives ?

Accepted Answer

20 µg

Answer

15 µg

Answer

25 µg

Answer

30 µg

Question 7

Consider the following list of cancers:

1. Ovarian cancer
2. Colon cancer
3. Endometrial cancer
4. Breast cancer

What is the effect of combined oral contraceptive pills on the above?

Accepted Answer

Protection against 1, 2 and 3

Answer

Increased risk of 3 and 4 only

Answer

Decreased risk of 1 and 2 only

Answer

Increased risk of 2 and 3 only

Question 8

Which one of the following is not a third generation progestogen used in combined oral contraceptive pills ?

Accepted Answer

Levonorgestrel

Answer

Norgestimate

Answer

Gestodene

Answer

Desogestrel

Question 9

Post coital contraception is achieved by all except

Accepted Answer

High degree of progesterone

Answer

By administration of RU 486

Answer

Administration of prostaglandins

Answer

High dose estrogens

Question 10

Mifepristone used for inducing abortion acts on :

Accepted Answer

Progesterone receptors

Answer

Uterine contractility

Answer

Hypothalamopituitary ovarian axis

Answer

All of the options

Endocrine Pharmacology — MCQs

Endocrine Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?